Ultragenyx Pharmaceutical | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Agios Pharmaceuticals USD 70.41M 18.04M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Insmed USD 311.68M 72.45M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Kyowa Hakko Kirin JPY 177.9B 38.62B 2025-06
MacroGenics USD 55.53M 3.78M 2024-12
Moderna USD 1.57B 32M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
PTC Therapeutics USD 627.81M 32.42M 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


Ultragenyx Pharmaceutical Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.